|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,169.90 INR | +1.94% |
|
+1.50% | -7.96% |
| 08-03 | Dr. Reddy's Laboratories Says US FDA Approves Rituximab Biosimilar for US Market | MT |
| 07-31 | Indian shares notch monthly gains as AI unwind, upbeat earnings draw foreign inflows | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Other Pharmaceuticals | +1.94% | +1.50% | -7.96% | -4.08% | +24.41% | 10.01B |  | | |
Select your edition
All financial news and data tailored to specific country editions
